Fullerton Fund Management CO Ltd. Zai Lab LTD Transaction History

Fullerton Fund Management CO Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $18,501 - $35,455	-337 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $35,385 - $60,110	337 New	337 $36,000
Q3 2020 Nov 16, 2020	SELL	$73.3 - $89.48 $4.26 Million - $5.2 Million	-58,058 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $2.65 Million - $4.47 Million	54,179 Added 1396.73%	58,058 $4.77 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $151,668 - $243,989	3,879 New	3,879 $200,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.65B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.